SavedAdd your journal

Journals / MN Oftalmoloji / 2007 / Cilt: 14 - Sayı: 2

A possible toxic endophthalmitis following intravitreal triamcinolone acetonide İnjection

İntravitreal triamsinolon asetonit enleksiyonu sonrası gelişen olası bir toksin endoftalmi

Kemal ÖRNEK
Sefer Ogün BÖLÜK
Sadık KAVAKLI
Pages
150–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here the course of a toxic endophthalmitis case following injection which improved in short time after treatment is being presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intravitreal triamcinoione acetonide injection is known to be effective in the treatment ofmacular edema due to various causes.
📊
Key Findings & Data:One of the most disasterous complications is the development of endophthalmitis.
💡
Conclusion & Impact:Here the course of a toxic endophthalmitis case following injection which improved in short time after treatment is being presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Triamsinolon asetonit · Endoftalmit · İlaç toksisitesi

Abstract

Intravitreal triamcinoione acetonide injection is known to be effective in the treatment ofmacular edema due to various causes. One of the most disasterous complications is the development of endophthalmitis. Here the course of a toxic endophthalmitis case following injection which improved in short time after treatment is being presented.

Özet

intravitreal triamsinolon asetonit enjeksiyonu çeşitli nedenlerle oluşan makula ödemi tedavisinde etkili bir tedavi yöntem olduğu bilinmektedir. En korkutucu komplikasyonlardan birisi ise endoftalmi gelişimidir. Burada enjeksiyon sonrası gelişen bir toksik endoftalmi olgusunun seyri ve kısa süre içerisinde tedaviye verdiği olumlu yanıt sunulmaktadır.

🔖

Cite This Article

ÖRNEK, K., BÖLÜK, S. O., KAVAKLI, S. (2007). A possible toxic endophthalmitis following intravitreal triamcinolone acetonide İnjection. MN Oftalmoloji, Cilt: 14 - Sayı: 2, 150–151. https://ajindex.com/articles/295956

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, MartidisA. İntravitreal triamcinolone acetonide for diabetic ma cular edema. Retina 2005;25: 828-34
  2. Young S, Larkın G, Branley M, Lightman S. Safety and effi cacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001; 29:2-6
  3. Danis RP, Ciulla TA, Pratt LM, Anliker W. İntravitreal triamci nolone acetonide in exudative age-related macular degene ration. Retina 2000;20:244-50
  4. Tewari HK, Sony P, Chawla R, Garg SP, Venkatesh P. Pros pective evaluation of intravitreal triamcinolone acetonide in jection in macular edema associated with retinal vascular disorders Eur J Ophthalmol 2005;15:619-26
  5. Kreissig I, Degenring RF, Jonas JB. İntravitreal triamcinolone acetonide Complication of infectious and sterile endophthal mitis] Ophthalmologe 2006; 103: 30-4
  6. Sutter FK, Gillies MC. Pseudo - endophthalmitis after intra vitreal injection of triamcinolone. Br J Ophthalmol 2003; 87:972-4
  7. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A Infectious and presumed noninfectious en dophthalmitis after intravitreal triamcinolone acetonide injec tion Retina 2003;23: 686-91